Company Registration No. 16899180 (England and Wales)
Self Reinvention Therapy Limited
Unaudited accounts
for the period from 9 December 2025 to 30 June 2026
Self Reinvention Therapy Limited
Unaudited accounts
Contents
Self Reinvention Therapy Limited
Company Information
for the period from 9 December 2025 to 30 June 2026
Director
Megan Poppy Moreno
Company Number
16899180 (England and Wales)
Registered Office
71-75 Shelton Street
Covent Garden
London
WC2H9JQ
United Kingdom
Accountants
Rise Accounting Limited
131 Finsbury Pavement
London
EC2A 1NT
Self Reinvention Therapy Limited
Statement of financial position
as at 30 June 2026
Called up share capital
10
Capital contribution reserve
1,821
Profit and loss account
(1,831)
For the period ending 30 June 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 16 September 2026 and were signed on its behalf by
Megan Poppy Moreno
Director
Company Registration No. 16899180
Self Reinvention Therapy Limited
Notes to the Accounts
for the period from 9 December 2025 to 30 June 2026
Self Reinvention Therapy Limited is a private company, limited by shares, registered in England and Wales, registration number 16899180. The registered office is 71-75 Shelton Street, Covent Garden, London, WC2H9JQ, United Kingdom.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
These financial statements for the period from 9 December 2025 to 30 June 2026 are the first financial statements that comply with FRS 102 Section 1A Small Entities. The date of transition is 9 December 2025.
The transition to FRS 102 Section 1A Small Entities has resulted in a small number of changes in accounting policies to those used previously.
The nature of these changes and their impact on opening equity and profit for the comparative period are explained in the notes below.
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
The accounts are presented in £ sterling.
4
Capital contribution reserve
During the year, the Company received a capital contribution of £1821 from Megan Poppy Moreno (Director).The contribution is non-repayable, no shares were issued in consideration, and no interest is payable. The amount has been credited directly to a capital contribution reserve within equity. There were no outstanding balances with Megan Poppy Moreno (Director) at the balance sheet date.
5
Average number of employees
During the period the average number of employees was 1.